While rare, subclonal IDH1 mutations are present in a subset of IDH-mutant astrocytomas of all grades, which may lead to a mismatch between IHC results and genetic/epigenetic classification. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).